Industry standards have an acceptable error range of ±15% between the meter reading and the lab reading on the same blood sample.1
CONTOUR® NEXT LINK 2.4 meter provides remarkable accuracy with blood glucose readings that are within ±10% of lab results.2
This means the readings from your CONTOUR® NEXT LINK 2.4 meter may be closer to lab results, which can help you make even better insulin dosing decisions.3
You depend on your meter to help you make important decisions with respect to blood glucose management. For example, you might rely on your meter to:
To have confidence that you are making the right decisions based on accurate readings, you need the values on your meter to reflect your actual blood glucose as closely as possible. A reading that is off by 15% vs. a reading that is off by only 10% could mean that you inject too much insulin or eat too little carbohydrates, which could put you at risk for a hypoglycemic episode.
Highly accurate readings, such as those provided by the CONTOUR® NEXT meters, can help you make the right decisions when they matter most.
1. Regulations based on Health Canada−recognized ISO 15197:2013 standards require results within ±15%, specifically: ≥95% of results must fall within ±0.83 mmol/L for blood glucose concentrations <5.55 mmol/L and within ±15% for blood glucose concentrations ≥5.55 mmol/L. 2. CONTOUR® NEXT LINK 2.4 meter meets ±10% accuracy vs. laboratory method for blood glucose concentrations, specifically: 99.3% of results within ±10% for blood glucose concentrations ≥5.55 mmol/L, and 98.4% of results within ±0.56 mmol/L accuracy vs. laboratory method for blood glucose concentrations <5.55 mmol/L. 3. AADE Position Statement, 2010.
* Pharmacy Practice+ and Profession Santé 2017 Survey on OTC Counselling and Recommendations (re: pharmacists) † The survey relates to the brand, not speciﬁc blood glucose meter models. The CONTOUR®NEXT ONE and CONTOUR®NEXT LINK 2.4 meter models were launched in February 2017 and April 2017 respectively, and were not on the market during the time of the survey.
Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google Inc. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners. For a full list of trademarks click here
The company that brings you CONTOUR® products has a new name. Introducing Ascensia Diabetes Care. 2920 Matheson Blvd East, Mississauga, Ontario, L4W 5R6 Tel: 1-800-268-7200
FrançaisTrademarksGeneral Conditions of UsePrivacy StatementContact usSitemapPhone Compatibility List
©2017 Ascensia Diabetes Care Canada Inc. Last Updated February 2018
You are now leaving this website. The website you are about to access is not owned or controlled by Ascensia Diabetes Care Canada Inc.
Ascensia assumes no responsibility for, and makes no representation as to the accuracy of any content contained on the website you are about to access.